Quickly Spot Consensus Among the World’s Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
2%
downside
3 price targets
|
0
%
|
|
|
|
3%
downside
3 price targets
|
0
%
|
|
|
|
4%
downside
13 price targets
|
0
%
|
|
|
279
Tango Therapeutics
TNGX
$3.32B
|
4%
downside
5 price targets
|
0
%
|
|
|
4%
downside
3 price targets
|
0
%
|
|
|
|
5%
downside
3 price targets
|
0
%
|
|
|
|
5%
downside
4 price targets
|
0
%
|
|
|
|
5%
downside
5 price targets
|
0
%
|
|
|
|
5%
downside
4 price targets
|
0
%
|
|
|
|
6%
downside
3 price targets
|
0
%
|
|
|
286
Macerich
MAC
$5.69B
|
6%
downside
5 price targets
|
0
%
|
|
|
7%
downside
3 price targets
|
0
%
|
|
|
|
7%
downside
3 price targets
|
0
%
|
|
|
|
7%
downside
4 price targets
|
0
%
|
|
|
|
7%
downside
5 price targets
|
0
%
|
|
|
|
7%
downside
3 price targets
|
0
%
|
|
|
|
7%
downside
7 price targets
|
0
%
|
|
|
|
7%
downside
4 price targets
|
0
%
|
|
|
|
8%
downside
5 price targets
|
0
%
|
|
|
|
8%
downside
3 price targets
|
0
%
|
|
|
|
8%
downside
6 price targets
|
0
%
|
|
|
|
8%
downside
4 price targets
|
0
%
|
|
|
|
10%
downside
7 price targets
|
0
%
|
|
|
|
10%
downside
3 price targets
|
0
%
|
|
|
|
10%
downside
4 price targets
|
0
%
|
|